来自MSN1 个月
Leerink Partners Downgrades LAVA Therapeutics N.V. (LVTX)
See our leaderboard of companies with the largest price target upside. The projected annual revenue for LAVA Therapeutics N.V. is 0MM, a decrease of 100.00%. The projected annual non-GAAP EPS is ...
来自MSN1 个月
JMP Securities Downgrades LAVA Therapeutics N.V. (LVTX)
See our leaderboard of companies with the largest price target upside. The projected annual revenue for LAVA Therapeutics N.V. is 0MM, a decrease of 100.00%. The projected annual non-GAAP EPS is ...